• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by British American Tobacco Industries p.l.c.

    5/1/25 7:49:52 AM ET
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $BTI alert in real time by email
    6-K 1 form6-k.htm REPORT OF FOREIGN PRIVATE ISSUER

     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


     
    FORM 6-K
     

     
    REPORT OF FOREIGN PRIVATE ISSUER
    Pursuant to Rule 13a-16 or 15d-16
    under the Securities Exchange Act of 1934
     
    May 1, 2025
     
    Commission File Number: 001-38159


     
    BRITISH AMERICAN TOBACCO P.L.C.
    (Translation of registrant’s name into English)


     
    Globe House
    4 Temple Place
    London WC2R 2PG
    United Kingdom
    (Address of principal executive office)


     
    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
     
    Form 20-F ☒              Form 40-F ☐
     
     
     

     

    This report includes materials as exhibits that have been published and made available by British American Tobacco p.l.c. as of the date indicated in the relevant exhibit description.

    EXHIBIT INDEX
     
    Exhibit
     
    Description
     
          
     
    Exhibit 1

    Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Voting Rights and Capital” dated April 1, 2025.
         
    Exhibit 2
     
    Press Release entitled “Transaction in own shares” dated April 2, 2025.
         
    Exhibit 3
     
    Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated April 2, 2025.
         
    Exhibit 4

    Press Release entitled “Transaction in own shares” dated April 3, 2025.
         
    Exhibit 5
      Press Release entitled “British American Tobacco p.l.c. – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated April 3, 2025.
         
    Exhibit 6
      Press Release entitled “British American Tobacco p.l.c. – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated April 3, 2025.
         
    Exhibit 7   Press Release entitled “Transaction in own shares” dated April 4, 2025.
         
    Exhibit 8
      Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated April 4, 2025.
         
    Exhibit 9
     
    Press Release entitled “Transaction in own shares” dated April 7, 2025.
         
    Exhibit 10
      Press Release entitled “British American Tobacco p.l.c. – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated April 7, 2025.
         
    Exhibit 11
      Press Release entitled “Transaction in own shares” dated April 8, 2025.
         
    Exhibit 12
     
    Press Release entitled “Transaction in own shares” dated April 9, 2025.
         
    Exhibit 13
      Press Release entitled “Transaction in own shares” dated April 10, 2025.
         
    Exhibit 14
      Press Release entitled “British American Tobacco p.l.c. – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated April 10, 2025.
         
    Exhibit 15

    Press Release entitled “Transaction in own shares” dated April 11, 2025.
         
    Exhibit 16
     
    Press Release entitled “British American Tobacco p.l.c. – TR-1: Notification of major holdings” dated April 11, 2025.
         
    Exhibit 17
     
    Press Release entitled “Transaction in own shares” dated April 14, 2025.
         
    Exhibit 18
     
    Press Release entitled “British American Tobacco p.l.c. – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated April 14, 2025.
         
    Exhibit 19  
    Press Release entitled “Transaction in own shares” dated April 15, 2025.
         
    Exhibit 20
      Press Release entitled “British American Tobacco p.l.c. – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated April 15, 2025.
         
    Exhibit 21
     
    Press Release entitled “Transaction in own shares” dated April 16, 2025.
         
    Exhibit 22
     
    Press Release entitled “AGM 2025 – Chair’s Address” dated April 16, 2025.
         
    Exhibit 23
     
    Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Results of Voting at the 2024 Annual General Meeting” dated April 16, 2025.
         
    Exhibit 24   Press Release entitled “Transaction in own shares” dated April 17, 2025.
         
    Exhibit 25  
    Press Release entitled “Transaction in own shares” dated April 22, 2025.
         
    Exhibit 26   Press Release entitled “British American Tobacco p.l.c. – TR-1: Notification of major holdings” dated April 22, 2025.
         
    Exhibit 27
      Press Release entitled “British American Tobacco p.l.c. – Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them” dated April 22, 2025.

    Exhibit  
    Description
         
    Exhibit 28
      Press Release entitled “Transaction in own shares” dated April 23, 2025.
         
    Exhibit 29
      Press Release entitled “British American Tobacco p.l.c. – TR-1: Notification of major holdings” dated April 23, 2025.
         
    Exhibit 30
     
    Press Release entitled “Transaction in own shares” dated April 24, 2025.
         
    Exhibit 31
     
    Press Release entitled “Transaction in own shares” dated April 25, 2025.
         
    Exhibit 32
     
    Press Release entitled “Transaction in own shares” dated April 28, 2025.
       

    Exhibit 33
     
    Press Release entitled “British American Tobacco p.l.c. – TR-1: Notification of major holdings” dated April 28, 2025.
         
    Exhibit 34
      Press Release entitled “Transaction in own shares” dated April 29, 2025.
         
    Exhibit 35
      Press Release entitled “British American Tobacco p.l.c. (the “Company”) – Share Buyback Programme” dated April 29, 2025.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
     
     
     
    British American Tobacco p.l.c.
     
       
     
           
     
    By:
    /s/ Nancy Jiang
     
        Name: 
    Nancy Jiang  
        Title:   
    Senior Assistant Company Secretary
     
           
     
    Date:  May 1, 2025







    Get the next $BTI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BTI

    DatePrice TargetRatingAnalyst
    4/30/2025Buy
    BofA Securities
    1/27/2025Neutral → Buy
    UBS
    10/3/2024$33.00Overweight → Underweight
    Morgan Stanley
    1/23/2024Neutral
    UBS
    11/1/2023$38.00Overweight
    Morgan Stanley
    9/25/2023Buy
    Citigroup
    9/1/2023Buy → Hold
    Argus
    3/13/2023Overweight → Neutral
    JP Morgan
    More analyst ratings